Impact Factor
4.17
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.72
1,288 total citations
h5-index
37
h5 depth signal
Cited share
89.6%
181 of 202
Total citations
1,288
Citation footprint
Metric signal
6.85
External metric anchor
Self-citation
0.5%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
714
United States
305
Italy
27
Japan
27
India
22
Citing Fields of Research
Cancer & Development
310
Oncology
298
Noncoding RNA
218
Cancer, Autophagy & Apoptosis
215
Immunology
152
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,213
Articles tracked across the journal lifetime
Indexed publication set
202
181 cited publications
Last 12 months
89
7.4 publications/month
Open access share
100.0%
89 OA publications in the last year
Leading citing country
China
714 citing publications
Leading citing field
Cancer & Development
310 citing publications
Latest tracked publication
10 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan.-Feb. 2002-
v1n1, Jan.-Feb. 2002-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer, Autophagy & Apoptosis
Noncoding RNA
Immunology
Breast Cancer
Oncology
Cancer & Development
Broad Categories
Neoplasms
Therapeutics
Noncoding RNA
Cancer, Autophagy & Apoptosis
Cancer & Development
Immunology
Hematology
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1080/15384047.2026.2737476
Open DOI
UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitination
04
05
DOI 10.1080/15384047.2026.2732738
Open DOI
Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncology
06
07
DOI 10.1080/15384047.2026.2740300
Open DOI
Statement of Retraction: Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1
We, the Editors and Publisher of Cancer Biology & Therapy, have retracted the following article:Liu, G., Zhao, X., Zhou, J., Cheng, X., Ye, Z., & Ji, Z. (2018). Long non-coding RNA MEG3 suppresses ...
08
DOI 10.1080/15384047.2026.2740282
Open DOI
Statement of retraction: Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway
We, the Editors and Publisher of Cancer Biology & Therapy, have retracted the following article:Weng, Y. C., Ma, J., Zhang, J., & Wang, J. C. (2019). Long non-coding RNA LINC01133 silencing exerts ...
09
10
DOI 10.1080/15384047.2026.2725357
Open DOI
Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer with high brain metastatic (BM) potential. Tumor-derived exosomes are implicated as key modulators during the formation of the pre-metastatic niche (PMN). However,...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.